Laguna Pharmaceuticals, Inc.
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Private
- Established
- 2006-01-01
- Employees
- 1
- Market Cap
- -
- Website
- http://www.chanrx.com
Clinical Trials
2
Active:0
Completed:1
Trial Phases
2 Phases
Phase 2:1
Phase 3:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (2 trials with phase data)• Click on a phase to view related trials
Phase 2
1 (50.0%)Phase 3
1 (50.0%)Safety and Efficacy of Vanoxerine for the Conversion of Subjects With Recent Onset Atrial Fibrillation or Flutter to Normal Sinus Rhythm
Phase 3
Terminated
- Conditions
- Atrial Fibrillation or Flutter
- Interventions
- Drug: Placebo
- First Posted Date
- 2015-05-27
- Last Posted Date
- 2016-10-17
- Lead Sponsor
- Laguna Pharmaceuticals, Inc.
- Target Recruit Count
- 41
- Registration Number
- NCT02454283
Safety and Efficacy of Vanoxerine for Conversion of Atrial Fibrillation or Flutter to Normal Sinus Rhythm
Phase 2
Completed
- Conditions
- Symptomatic Atrial FibrillationAtrial Flutter
- Interventions
- Drug: Placebo
- First Posted Date
- 2012-09-24
- Last Posted Date
- 2015-12-22
- Lead Sponsor
- Laguna Pharmaceuticals, Inc.
- Target Recruit Count
- 104
- Registration Number
- NCT01691313
News
No news found